Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edna Keeney

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Pharmacoeconomics|February 16, 2018
Different Methods for Modelling Severe Hypoglycaemic Events: Implications for Effectiveness, Costs and Health UtilitiesEdna Keeney, Dalia Dawoud, Sofia Dias
Pharmacoeconomics|March 10, 2019
Correction to: Different Methods for Modelling Severe Hypoglycaemic Events: Implications for Effectiveness, Costs and Health UtilitiesEdna Keeney, Dalia Dawoud, Sofia Dias
The Cochrane Database of Systematic Reviews|December 7, 2018
Dual combination therapy versus long-acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta-analysisYuji Oba, Edna Keeney, Namratta Ghatehorde, et al.
BJU International|March 17, 2022
Contribution of the Cluster randomised triAl of PSA testing for Prostate cancer (CAP) to the ongoing debate on the value of prostate cancer screeningRichard M Martin, Padraig Dixon, Emma Turner, et al.
Systematic Reviews|December 15, 2016
Data extraction for complex meta-analysis (DECiMAL) guideHugo Pedder, Grammati Sarri, Edna Keeney, et al.
Pharmacoeconomics|July 17, 2021
Response to Comment on Delphi Analysis of Relevant Comparators in a Cost-Effectiveness Model of Prostate Cancer ScreeningEdna Keeney, Howard Thom, Emma Turner, et al.
Pharmacoeconomics|April 2, 2021
Using a Modified Delphi Approach to Gain Consensus on Relevant Comparators in a Cost-Effectiveness Model: Application to Prostate Cancer ScreeningEdna Keeney, Howard Thom, Emma Turner, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 16, 2022
Can polygenic risk scores contribute to cost-effective cancer screening? A systematic reviewPadraig Dixon, Edna Keeney, Jenny C Taylor, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 15, 2022
Systematic Review of Cost-Effectiveness Models in Prostate Cancer: Exploring New Developments in Testing and DiagnosisEdna Keeney, Howard Thom, Emma Turner, et al.
BMC Health Services Research|March 10, 2022
An observational cohort study of health outcomes and costs associated with early pregnancy assessment units in the UKEdna Keeney, Maria Memtsa, Venetia Goodhart, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Pharmacoeconomics|February 16, 2018
Different Methods for Modelling Severe Hypoglycaemic Events: Implications for Effectiveness, Costs and Health UtilitiesEdna Keeney, Dalia Dawoud, Sofia Dias
Pharmacoeconomics|March 10, 2019
Correction to: Different Methods for Modelling Severe Hypoglycaemic Events: Implications for Effectiveness, Costs and Health UtilitiesEdna Keeney, Dalia Dawoud, Sofia Dias
The Cochrane Database of Systematic Reviews|December 7, 2018
Dual combination therapy versus long-acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta-analysisYuji Oba, Edna Keeney, Namratta Ghatehorde, et al.
BJU International|March 17, 2022
Contribution of the Cluster randomised triAl of PSA testing for Prostate cancer (CAP) to the ongoing debate on the value of prostate cancer screeningRichard M Martin, Padraig Dixon, Emma Turner, et al.
Systematic Reviews|December 15, 2016
Data extraction for complex meta-analysis (DECiMAL) guideHugo Pedder, Grammati Sarri, Edna Keeney, et al.
Pharmacoeconomics|July 17, 2021
Response to Comment on Delphi Analysis of Relevant Comparators in a Cost-Effectiveness Model of Prostate Cancer ScreeningEdna Keeney, Howard Thom, Emma Turner, et al.
Pharmacoeconomics|April 2, 2021
Using a Modified Delphi Approach to Gain Consensus on Relevant Comparators in a Cost-Effectiveness Model: Application to Prostate Cancer ScreeningEdna Keeney, Howard Thom, Emma Turner, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 16, 2022
Can polygenic risk scores contribute to cost-effective cancer screening? A systematic reviewPadraig Dixon, Edna Keeney, Jenny C Taylor, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 15, 2022
Systematic Review of Cost-Effectiveness Models in Prostate Cancer: Exploring New Developments in Testing and DiagnosisEdna Keeney, Howard Thom, Emma Turner, et al.
BMC Health Services Research|March 10, 2022
An observational cohort study of health outcomes and costs associated with early pregnancy assessment units in the UKEdna Keeney, Maria Memtsa, Venetia Goodhart, et al.
Pageof 3